Stockscreener 앱 받기
194.07
0.80%
-1.57
Becton Dickinson Co 주식(BDX)의 최신 뉴스
Becton, Dickinson and Company (NYSE:BDX) Shapes Global Healthcare - Kalkine Media
Becton Dickinson EVP sells $120,000 in company stock - MSN
Insider Sell: Michael Feld Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
Feld, Becton Dickinson EVP, sells $14509 in stock By Investing.com - Investing.com Nigeria
Feld, Becton Dickinson EVP, sells $14509 in stock - Investing.com
BD Appoints Bilal Muhsin as Executive Vice President and President of Future Connected Care Segment - Quantisnow
BD Expands BD MAX™ System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - Quantisnow
Banque de Luxembourg S.A. Boosts Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Franklin Lakes OKs affordable housing on Becton Dickinson site - Bergen Record
DAVENPORT & Co LLC Has $120.08 Million Position in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson (BDX): Evaluating Valuation After New Immunology Partnership with University of Pennsylvania - Yahoo Finance
BD faces hernia mesh lawsuit from Tela Bio - MassDevice
Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly - Benzinga
Trust Co. of Vermont Lowers Stake in Becton, Dickinson and Company $BDX - MarketBeat
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly - Reuters
BD and Penn Institute Ink Collaboration to Advance Immunotherapy - Yahoo Finance
IV Dressing Market Set for Dynamic Rise with Key Players Becton, - openPR.com
Is Becton Dickinson and Company stock a safe haven asset2025 Momentum Check & Accurate Trade Setup Notifications - ulpravda.ru
Becton Dickinson Faces Antitrust Suit Over Hernia Mesh Products - Bloomberg Law News
BECTON DICKINSON & CO ($BDX) CEO 2025 Pay Revealed - Quiver Quantitative
Form DEF 14A BECTON DICKINSON & CO For: Dec 12 - StreetInsider
Becton Dickinson, University of Pennsylvania partner on human immune profiling - TipRanks
Becton, Dickinson, University of Pennsylvania to Collaborate on Immune Profiling - 富途牛牛
BD and Penn Institute for Immunology and Immune Health Collaborate to Advance Immunotherapy through Flow Cytometry - Finviz
Inside the 1,000-person immune study aiming to decode disease defenses - Stock Titan
Insider Sell: Michael Garrison Sells Shares of Becton Dickinson & Co (BDX) - GuruFocus
BECTON DICKINSON Executive Sells Shares Under Trading Plan - TradingView — Track All Markets
VP Garrison Sells 629 ($123.3K) Of Becton Dickinson & Co [BDX] - TradingView — Track All Markets
Can Becton Dickinson and Company (BOX) stock reach $200 price targetBear Alert & Verified Momentum Stock Alerts - Bollywood Helpline
The Magnificent 7 Are So Yesterday. These Are AI’s Next Big Winners - Forbes
RBC Capital Raises Becton Dickinson (BDX) Price Target to $210 | - GuruFocus
RBC Capital Maintains Becton Dickinson & Co(BDX.US) With Hold Rating, Raises Target Price to $210 - 富途牛牛
Becton Dickinson & Co. stock underperforms Tuesday when compared to competitors - MarketWatch
Cardinal Capital Management Inc. Grows Holdings in Becton, Dickinson and Company $BDX - MarketBeat
These Surging Dividend Stocks Are the Next AI Winners and Wall Street Hates Them - Investing.com
BD Expands BD MAX System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - Finviz
Becton, Dickinson Expands Infection Diagnostics Offerings in Europe - marketscreener.com
BD expands diagnostic offerings with new IVDR-certified assays - Investing.com
Bd expands bd max(tm) system menu in partnership with Certest Biotec - marketscreener.com
Surprise Proposal For Part Of Becton Dickinson Site Shakes Up Franklin Lakes Housing Talks - dailyvoice.com
Bd Expands Bd Max™ System Menu In Partnership With Certest Biotec - TradingView — Track All Markets
BD expands diagnostic offerings with new IVDR-certified assays By Investing.com - Investing.com UK
Becton, Dickinson and Company Expands BD Max System Menu with New IVDR-Certified VIASURE Assays in Partnership with Certest Biotec - marketscreener.com
YieldBoost BDX From 2.1% To 5.9% Using Options - Nasdaq
Farmers Trust Co. Purchases New Stake in Becton, Dickinson and Company $BDX - MarketBeat
Lazard Asset Management LLC Acquires 654,930 Shares of Becton, Dickinson and Company $BDX - MarketBeat
What Does Wall Street See for Becton, Dickinson's Q3? - AOL.com
Benjamin Edwards Inc. Increases Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Banque Transatlantique SA Has $2.83 Million Stock Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety - GlobeNewswire
Becton Dickinson, Bio-Rad, and Thermo Fisher Propel Safety and Automation in Blood Collection Tubes—New Market Report Highlights $7Billion Opportunity - Yahoo Finance
Waters-Becton, Dickinson deal deadline expires in the US - MLex
Waters-Becton-Dickinson deal receives antitrust clearance in the US - MLex
Becton, Dickinson Reaches Analyst Target Price - Nasdaq
Becton Dickinson Shares Gain on Strategic Optimism and Product Launches - Ad-hoc-news.de
Morgan Stanley Highlights Positive Outlook for Becton, Dickinson (BDX) and the MedTech Sector - Finviz
OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC Has $2.60 Million Holdings in Becton, Dickinson and Company $BDX - MarketBeat
Becton, Dickinson and Company $BDX Shares Sold by Cary Street Partners Financial LLC - MarketBeat
Jefferies Adjusts PT on Becton, Dickinson and Co. to $220 From $215, Maintains Buy Rating - marketscreener.com
Jefferies raises Becton Dickinson stock price target to $220 on deal implications By Investing.com - Investing.com South Africa
0.63%
0.19%
자본화:
|
볼륨(24시간):